Balance Sheet Data

Sangamo Therapeutics, Inc. (SGMO)

$1.16

+0.09 (+8.41%)

Year
A/P
2018
Actual
2019
Actual
2020
Actual
2021
Actual
2022
Actual
2023
Projected
2024
Projected
2025
Projected
2026
Projected
2027
Projected
Total Cash 400.51384.99691.95464.72277.63504.69543.65585.62630.82679.52
Total Cash (%)
Account Receivables 5.0537.596.266.364.4713.8414.9116.0617.3018.64
Account Receivables (%)
Inventories -0.37-22.51-50.53-88.170-34.73-37.41-40.29-43.40-46.76
Inventories (%)
Accounts Payable 3.366.6712.559.7622.421212.9313.931516.16
Accounts Payable (%)
Capital Expenditure -43.07-20.67-14.71-23.28-20.17-29.44-31.71-34.16-36.80-39.64
Capital Expenditure (%)



To support growth, companies need to keep investing in capital items – including property, plants and equipment.
To calculate this net investment,we take capital expenditure (found in the company’s statement of cash flows) and subtract non-cash depreciation (found on the income statement).
Working capital refers to the cash a company needs for day-to-day operations.
The faster a company expands, the more cash it will need.
To calculate working capital, we take current assets and subtract current liabilities.
You can find both of these on a company’s balance sheet, which is published in its quarterly and annual financial statements.